21 Nov 2023
An intrepid solution for transfemoral treatment of mitral regurgitation
Sponsored by Medtronic
Anchorperson:
A. Duncan
Summary
In this session, get insights into the APOLLO EU trial and its current progress, obtain a comprehensive understanding of the latest data from the Early Feasibility TF trial, and discern which patients stand to benefit the most from this treatment.
Learning Objectives
- To learn more about the APOLLO EU trial and journey to date
- To understand the latest data on the Early Feasibility TF trial
- To understand which patients can best benefit from this treatment